Estimated antiretroviral therapy coverage among people living with HIV in EUR
EUR: Estimated antiretroviral therapy coverage among people living with HIV was 67.0% in 2025. ▲ Rising
Estimated antiretroviral therapy coverage among people living with HIV in EUR, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
EUR recorded 67.0% for estimated antiretroviral therapy coverage among people living with hiv in 2025. That is the highest value across all 26 years on record.
The figure is up 3.1% on the previous year and up 45.7% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in EUR peaked at 67.0% in 2025 and was at its lowest, 19.0%, in 2000.
The long-run direction has been consistently rising across the 26 years of available data.
Estimated antiretroviral therapy coverage among people living with HIV in EUR, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 19.0% | — |
| 2001 | 20.0% | +5.3% |
| 2002 | 22.0% | +10.0% |
| 2003 | 23.0% | +4.5% |
| 2004 | 24.0% | +4.3% |
| 2005 | 25.0% | +4.2% |
| 2006 | 27.0% | +8.0% |
| 2007 | 29.0% | +7.4% |
| 2008 | 31.0% | +6.9% |
| 2009 | 33.0% | +6.5% |
| 2010 | 35.0% | +6.1% |
| 2011 | 37.0% | +5.7% |
| 2012 | 39.0% | +5.4% |
| 2013 | 41.0% | +5.1% |
| 2014 | 44.0% | +7.3% |
| 2015 | 46.0% | +4.5% |
| 2016 | 50.0% | +8.7% |
| 2017 | 54.0% | +8.0% |
| 2018 | 57.0% | +5.6% |
| 2019 | 61.0% | +7.0% |
| 2020 | 63.0% | +3.3% |
| 2021 | 64.0% | +1.6% |
| 2022 | 65.0% | +1.6% |
| 2023 | 66.0% | +1.5% |
| 2024 | 65.0% | -1.5% |
| 2025 | 67.0% | +3.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 25.3% | 19.0% | 33.0% | 10 |
| 2010s | 46.4% | 35.0% | 61.0% | 10 |
| 2020s | 65.0% | 63.0% | 67.0% | 6 |
Countries ranked near EUR
More health data for EUR
- Mortality rate among children ages 5 to 9 years 0.7826 (2024)
- Population with primary reliance on polluting fuels and technologies 18.78 (2023)
- Proportion of population with primary reliance on fuels and 16.8% (2023)
- Population with primary reliance on fuels and technologies for 14.95 (2023)
- Prevalence of diabetes, crude 11.52 (2022)
- Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 94.0% (2025)
- Measles-containing-vaccine first-dose (MCV1) immunization coverage 92.0% (2025)
- New HIV infections 0.16 (2025)
- BCG immunization coverage among 1-year-olds (%) 94.0% (2025)
- Mean total cholesterol, crude 5 (2018)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in EUR?
- Estimated antiretroviral therapy coverage among people living with hiv in EUR was 67.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in EUR?
- The highest recorded value was 67.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in EUR?
- The lowest recorded value was 19.0% in 2000.
- How does EUR rank for estimated antiretroviral therapy coverage among people living with hiv?
- EUR ranks 8th out of 13 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in EUR?
- Over the last ten years it is up 45.7%. The long-run trend across the full record is rising.
- Where does this EUR data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).